Marjukka Myllärniemi is a Professor at the University of Helsinki, affiliated with the Faculty of Medicine , Clinicum , and Department of Medicine . Her research focuses on biomedicine with specializations in idiopathic pulmonary fibrosis (IPF), malignant mesothelioma, and lung disease pharmacology. Field of Science: Biomedicine Research Portal: Marjukka Myllärniemi Research Interests include: Idiopathic Pulmonary Fibrosis: Prognostic biomarkers, disease progression, quality of life assessment Malignant Mesothelioma: Asbestos exposure, tumor microenvironment, survival analysis Genetics and Proteomics: Identification of pathogenic variants and plasma biomarkers Clinical Trials: Evaluation of antiviral and fibrosis-targeting therapies Publication Trends (15 most recent) show expertise in: Lung disease pathology and treatment outcomes Genetic and proteomic biomarkers AI applications in histopathology Clinical trials for IPF and COVID-19 Supervised Work includes contributions to: Doctoral Programme in Biomedicine Doctoral Programme in Clinical Research Contact Information : Email: marjukka.myllarniemi@helsinki.fi Address: P.O. Box 372, Haartmaninkatu 4, 00014 University of Helsinki Phone: +358294126597, +358505560786
